Dr Reddys Laboratories intimates of completion of USFDA inspection
Receives Form 483 with 2 observations
Dr Reddys Laboratories announced that the audit of its API manufacturing plant at Srikakulam, Andhra Pradesh by the US FDA, has been completed on 04 April 2017. The Company has been issued a Form 483 with 2 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content